Tesofensine Weight Loss Therapy
An investigational oral weight loss medication that reduces appetite through a triple-neurotransmitter mechanism. Prescribed and monitored by the medical team at Rewind Anti-Aging of Miami.
A Dual-Action Oral Weight Loss Medication
Tesofensine is an oral weight loss medication that belongs to a class of drugs known as triple monoamine reuptake inhibitors. It works by blocking the reabsorption of three critical neurotransmitters: dopamine, serotonin, and noradrenaline. By increasing the availability of these neurotransmitters, tesofensine reduces appetite and food-seeking behavior. This central mechanism is what distinguishes it from GLP-1 medications, which work through the incretin system. In the trial that measured energy use directly, tesofensine increased fat oxidation and nighttime energy expenditure but showed no significant change in total 24-hour energy expenditure — its effect is appetite-led.
Originally developed for Alzheimer's and Parkinson's disease, researchers observed significant unexpected weight loss during early neurological trials — prompting a new line of research focused on obesity that produced some of the most impressive weight loss results seen in pharmaceutical development at that time.
At Rewind Anti-Aging of Miami, tesofensine is one of several medication options within our medical weight loss program. It is particularly well-suited for patients who prefer an oral capsule over weekly injections, those who have not responded adequately to GLP-1 receptor agonists, or patients seeking the metabolic-boosting component that GLP-1 medications do not provide.
The Triple Reuptake Mechanism
Tesofensine targets three neurotransmitters to attack weight loss from both sides — reducing intake and boosting metabolism.
Dopamine
Reducing Reward-Driven Eating
Dopamine is the brain's primary "reward" neurotransmitter. It drives the pleasure response to calorie-dense, highly palatable foods. By inhibiting dopamine reuptake, tesofensine increases dopamine availability so the brain receives a stronger reward signal from normal-sized meals — reducing the neurological drive to overeat and dampening cravings.
Serotonin
Controlling Appetite & Mood
Low serotonin levels are associated with increased carbohydrate cravings, emotional eating, anxiety, and depression. Tesofensine's serotonin reuptake inhibition helps regulate appetite signals, reduce emotional and stress-related eating, and improve overall mood during the weight loss process.
Noradrenaline
Fat Oxidation and Nighttime Energy Use
Inhibiting noradrenaline reuptake is thought to influence how the body uses energy. In the one human trial that measured this directly (Sjödin et al., 2010), tesofensine increased 24-hour fat oxidation and raised nighttime energy expenditure by about 4.6%, but showed no significant effect on total 24-hour energy expenditure. The trial concluded that tesofensine's effect on appetite is pronounced, while its effect on energy expenditure is slight.
The Lancet Phase II Trial
The most significant clinical evidence for tesofensine comes from a Phase II randomized, double-blind, placebo-controlled trial published in The Lancet in November 2008 (Astrup A, et al. Lancet. 2008;372:1906-1913).
The TIPO-1 study enrolled 203 obese adults (BMI 30-40) who were placed on a controlled diet and randomized to receive tesofensine at 0.25mg, 0.5mg, or 1.0mg daily, or placebo, for 24 weeks. After 24 weeks, diet and placebo produced a mean weight loss of 2.0%, while tesofensine at 0.25mg, 0.5mg, and 1.0mg with diet induced mean weight loss of 4.5%, 9.2%, and 10.6% respectively, greater than diet and placebo.
Researchers also noted improvements in waist circumference, blood lipid profiles, and quality-of-life measures across all treatment groups.
Dose-Dependent Weight Loss Results
24-week outcomes from the TIPO-1 Phase II trial, The Lancet (2008)
FDA Status
Tesofensine is not FDA-approved for weight loss in the United States. We believe it is essential that every patient understands this before considering treatment.
After the promising Phase II results, the development company planned Phase III trials, but those trials have faced delays and have not been completed in the U.S. as of this writing. Tesofensine remains available through licensed compounding pharmacies and is prescribed off-label by physicians who evaluate the existing clinical data and determine that the benefit-risk profile is appropriate.
At Rewind Anti-Aging of Miami, we do not prescribe any treatment without discussing its regulatory status, the quality and limitations of available evidence, and how it compares to FDA-approved alternatives. If you would prefer an FDA-approved option, we offer semaglutide and tirzepatide.
Tesofensine vs. GLP-1 Medications
Understanding the differences helps you and your provider choose the right approach for your body. For a detailed comparison, read our guide on tesofensine vs semaglutide.
| Factor | Tesofensine | GLP-1 Medications |
|---|---|---|
| Drug Class | Triple monoamine reuptake inhibitor | GLP-1 (or dual GLP-1/GIP) receptor agonist |
| Mechanism | Blocks dopamine, serotonin, noradrenaline reuptake | Mimics incretin gut hormones |
| Appetite Effect | Reduces reward-driven and emotional eating | Suppresses hunger via hypothalamus and gastric slowing |
| Metabolic Effect | Increased fat oxidation; no significant change in total 24-h energy expenditure (Sjödin 2010) | Improves insulin sensitivity, minimal metabolic boost |
| Administration | Daily oral capsule | Weekly subcutaneous injection |
| FDA Status | Not FDA-approved (available via compounding) | FDA-approved (Wegovy, Zepbound) |
| Clinical Data | Phase II trial (Lancet, 2008) | Multiple Phase III trials (NEJM, 2021-2022) |
| Avg. Weight Loss | Up to 10.6% in 24 weeks (reported as greater than diet and placebo) | 14.9% (semaglutide) to 22.5% (tirzepatide) in 68-72 weeks |
| Comparability | Not directly comparable — different trial designs, durations, and reporting conventions; no head-to-head study exists | Not directly comparable — see left |
| Key Side Effects | Dry mouth, insomnia, increased heart rate | Nausea, diarrhea, constipation |
The choice between tesofensine and a GLP-1 medication is not a matter of one being "better" — they work through entirely different biological pathways. Some patients respond well to one and not the other.
Who Is Tesofensine For?
Tesofensine may be a strong fit for patients in the following situations.
Prefer Oral Medication
If weekly self-injections are a barrier, tesofensine offers a once-daily capsule alternative — one of the most common reasons patients choose it over GLP-1 medications.
GLP-1 Non-Responders
Some patients do not achieve adequate weight loss with semaglutide or tirzepatide, or experience intolerable GI side effects. Tesofensine works through a completely different mechanism.
Appetite-Driven Plateaus
Tesofensine acts on the brain's reward and appetite pathways rather than the incretin system, so it may suit patients whose weight loss has stalled and who have not responded to GLP-1 medications. Its mechanism is appetite-led; trial data did not show a significant change in total daily energy expenditure.
Emotional or Reward-Driven Eating
Tesofensine's dopamine and serotonin effects specifically target the neurological patterns behind cravings, emotional eating, and food addiction — pathways GLP-1 medications do not address as directly.
Comfortable with Off-Label Prescribing
Tesofensine is not FDA-approved — it requires a patient who understands and accepts the regulatory context and values the clinical trial evidence despite the absence of Phase III data.
Tesofensine is not appropriate for patients with uncontrolled high blood pressure, cardiovascular disease, a history of stroke, or those taking MAO inhibitors or certain antidepressants. It is also not recommended as a first-line treatment for patients who are good candidates for FDA-approved GLP-1 medications — unless they have a specific reason to prefer the oral route or a different mechanism of action.
Side Effects
Because tesofensine acts on the central nervous system by increasing neurotransmitter availability, its side effect profile differs from GLP-1 medications. Transparency about these effects is a non-negotiable part of our informed-consent process.
The most frequently reported side effect, related to noradrenergic activity. Typically manageable with increased water intake.
Increased noradrenaline can affect sleep onset. Taking the medication in the morning rather than evening often resolves this.
A dose-dependent effect of noradrenaline reuptake inhibition. Heart rate is monitored at every follow-up visit.
Can occur from changes in gut motility and reduced food intake. Usually responds to increased fiber and hydration.
Most common during the first one to two weeks and tends to resolve as the body adjusts.
Contraindications
Tesofensine should not be prescribed to patients with:
- Uncontrolled hypertension
- Cardiovascular disease (heart attack, stroke, unstable angina, arrhythmia)
- Current use of MAO inhibitors
- History of stroke or transient ischemic attack (TIA)
- Severe anxiety disorders or insomnia
- Pregnancy or breastfeeding
- Concurrent use of certain antidepressants (SSRIs, SNRIs, tricyclics)
Before prescribing, our team conducts cardiovascular and neurological screening, reviews your complete medication list, and orders baseline blood work.
Your Tesofensine Treatment Journey
From consultation to optimization — every step is transparent and medically supervised.
Consultation & Screening
Your provider reviews your health history, current medications, cardiovascular health, and weight loss goals. Comprehensive lab work is ordered.
Informed Consent
Your provider discusses tesofensine's clinical evidence, FDA status, side effect profile, and how it compares to FDA-approved alternatives.
Prescription & Dosing
Tesofensine is typically started at a low dose and may be titrated upward. The medication is dispensed from a licensed compounding pharmacy.
Early Monitoring (Weeks 1-4)
Close monitoring of heart rate, blood pressure, sleep quality, and appetite changes. Most patients notice reduced cravings within two weeks.
Ongoing Follow-Ups
Monthly visits to track weight, vital signs, and side effects. Dose adjustments are made as needed to optimize results while maintaining safety.
Related Treatments
Semaglutide Therapy
GLP-1 receptor agonist with proven 14.9% average weight loss in the landmark STEP clinical trials.
Learn more →Tirzepatide Therapy
Dual GLP-1/GIP receptor agonist with up to 22.5% average weight loss in clinical trials.
Learn more →Lipotropic Injections
MIC and B12 injections that support fat metabolism and energy as part of a weight loss program.
Learn more →Explore Tesofensine in Depth
Tesofensine vs Semaglutide: Comparing Weight Loss Options
How tesofensine compares to GLP-1 medications for weight loss.
Best Peptides for Weight Loss
A comparison of the most effective weight loss therapies available.
Intermittent Fasting: Should You Try It?
How dietary strategies complement medical weight loss therapy.
Frequently Asked Questions
Is tesofensine FDA-approved?
No. Tesofensine is not FDA-approved for weight loss in the United States. It completed Phase II clinical trials with promising results but has not yet completed Phase III trials or received FDA approval. It is available through licensed compounding pharmacies and prescribed off-label by physicians based on the existing clinical evidence. At Rewind Anti-Aging of Miami, we are fully transparent about the regulatory status of every treatment we offer.
How much weight can I lose with tesofensine?
In the Phase II clinical trial published in The Lancet (2008), tesofensine at the highest dose (1.0mg) with diet induced a mean weight loss of 10.6% over 24 weeks, greater than diet and placebo, which produced 2.0%. Individual results vary depending on starting weight, dosage, diet, exercise, and metabolic factors. Our medical team sets realistic expectations during your consultation based on your specific health profile.
How is tesofensine different from semaglutide or tirzepatide?
Tesofensine works through a completely different mechanism. While semaglutide and tirzepatide are GLP-1 receptor agonists that suppress appetite by mimicking gut hormones, tesofensine is a triple monoamine reuptake inhibitor that blocks the reabsorption of dopamine, serotonin, and noradrenaline in the brain, which reduces appetite. Additionally, tesofensine is an oral capsule taken daily, whereas GLP-1 medications are weekly injections.
What are the side effects of tesofensine?
The most commonly reported side effects in clinical trials include dry mouth, insomnia, increased heart rate, constipation, and headache. These are related to its stimulant-like action on the central nervous system. Most side effects are mild to moderate and tend to diminish over time. Our medical team monitors you closely, including heart rate and blood pressure checks, to ensure safety throughout treatment.
Can I take tesofensine if I have high blood pressure?
Tesofensine is contraindicated in patients with uncontrolled hypertension because it can increase heart rate and, in some cases, blood pressure. If your hypertension is well-controlled with medication, your provider may consider tesofensine on a case-by-case basis with close monitoring. A thorough cardiovascular evaluation is part of our screening process before prescribing.
Can tesofensine be combined with other weight loss treatments?
In some cases, yes. Tesofensine may be combined with lipotropic injections or used alongside hormone optimization therapy for a multi-modal approach. However, it should not be combined with MAO inhibitors, other stimulant medications, or certain antidepressants. Our medical team evaluates your full medication list and health history to determine whether combination therapy is safe and appropriate for you.
Find Out If Tesofensine Is Right for You
Schedule a consultation with our medical team to discuss your weight loss goals, review your health profile, and determine whether tesofensine — or another medication in our program — is the best fit for your body.
⚕ Medical Disclaimer
The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. All treatments at Rewind Anti-Aging of Miami are performed under the supervision of licensed medical professionals. Individual results may vary. Consult your physician before beginning any new treatment protocol.
Meet our clinical team →Areas We Serve in Miami & South Florida
Our clinic at 24 NW 29th Street is in Wynwood & Midtown, minutes from Edgewater and Brickell. We also care for patients across Coral Gables, Aventura, Key Biscayne, and Doral — plus the entire state of Florida via telehealth.